{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:37:24Z","timestamp":1794512244044,"version":"4.9.1"},"reference-count":43,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Korean government (MSIT)","award":["RS-2023-NR077257"],"award-info":[{"award-number":["RS-2023-NR077257"]}]},{"name":"the Korean government (MSIT)","award":["RS-2024-00422678"],"award-info":[{"award-number":["RS-2024-00422678"]}]},{"name":"the Korean government (MSIT)","award":["2022R1F1A1074216"],"award-info":[{"award-number":["2022R1F1A1074216"]}]},{"name":"the Korean government (MSIT)","award":["K2419861"],"award-info":[{"award-number":["K2419861"]}]},{"name":"the Korean government (MSIT)","award":["RS-2022-KH129263"],"award-info":[{"award-number":["RS-2022-KH129263"]}]},{"name":"the Ministry of Education of Korea through NRF, and Korea University","award":["RS-2023-NR077257"],"award-info":[{"award-number":["RS-2023-NR077257"]}]},{"name":"the Ministry of Education of Korea through NRF, and Korea University","award":["RS-2024-00422678"],"award-info":[{"award-number":["RS-2024-00422678"]}]},{"name":"the Ministry of Education of Korea through NRF, and Korea University","award":["2022R1F1A1074216"],"award-info":[{"award-number":["2022R1F1A1074216"]}]},{"name":"the Ministry of Education of Korea through NRF, and Korea University","award":["K2419861"],"award-info":[{"award-number":["K2419861"]}]},{"name":"the Ministry of Education of Korea through NRF, and Korea University","award":["RS-2022-KH129263"],"award-info":[{"award-number":["RS-2022-KH129263"]}]},{"DOI":"10.13039\/501100003710","name":"the Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["RS-2023-NR077257"],"award-info":[{"award-number":["RS-2023-NR077257"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"the Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["RS-2024-00422678"],"award-info":[{"award-number":["RS-2024-00422678"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"the Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["2022R1F1A1074216"],"award-info":[{"award-number":["2022R1F1A1074216"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"the Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["K2419861"],"award-info":[{"award-number":["K2419861"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"the Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["RS-2022-KH129263"],"award-info":[{"award-number":["RS-2022-KH129263"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: The dysregulation of NLRP3 inflammasome activation has been established as a key driver of inflammatory disease pathology, which marks NLRP3 as an attractive therapeutic target. However, the clinical development of NLRP3 inhibitors such as MCC950 has been hampered by their associated toxicity profiles, highlighting an unmet clinical need. Methods: Herein, we present LMT2368, a novel urea-based NLRP3 inhibitor identified through screening of urea-based derivatives from our in-house compound library. Results: Biolayer interferometry confirmed direct binding of LMT2368 to the NLRP3 NACHT domain with a (KD = 27.4 \u00b1 1.2 \u03bcM which was superior to MCC950. Molecular docking studies predicted enhanced binding interactions for LMT2368, consistent with its improved biological activity. In LPS-primed macrophages, LMT2368 dose-dependently suppressed IL-1\u03b2 secretion (IC50 = 0.8 \u03bcM in J774A.1 cells) and caspase-1 activation without affecting NF-\u03baB signaling. Importantly, LMT2368 inhibited ASC oligomerization and pyroptosis while maintaining excellent safety margins (CC50 &gt; 50 \u03bcM). In a murine model of LPS-induced acute lung injury, LMT2368 (10 mg\/kg) reduced bronchoalveolar lavage fluid immune cell infiltration by 68% (p &lt; 0.001), suppressed pro-inflammatory cytokine release (IL-1\u03b2\/IL-6\/TNF-\u03b1), and preserved lung histoarchitecture. Notably, LMT2368 showed selectivity for NLRP3 inhibition without affecting TNF-\u03b1\/IL-6 production during TLR4 priming in monocytic cell lines. Conclusions: Together, these findings establish LMT2368 as a promising lead compound for developing safer NLRP3 inhibitors with therapeutic potential for inflammasome-driven diseases.<\/jats:p>","DOI":"10.3390\/pharmaceutics17101241","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:27:53Z","timestamp":1758623273000},"page":"1241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["LMT2368 (1-(4-Chlorophenyl)-3-(3-fluoro-5-(trifluoromethyl)phenyl)urea) Negatively Regulates Inflammation by Inhibiting NLRP3 Inflammasome Activation"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-1185","authenticated-orcid":false,"given":"Thai Uy","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Biomedical Science, College of Medicine, Korea University, Seoul 73 Goryeodae-ro, Seongbuk-gu, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jeong","family":"Kwon","sequence":"additional","affiliation":[{"name":"Brain Korea 21 Fostering Outstanding Universities for Research, Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghoon","family":"Hurh","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, College of Medicine, Korea University, Seoul 73 Goryeodae-ro, Seongbuk-gu, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kale","sequence":"additional","affiliation":[{"name":"Brain Korea 21 Fostering Outstanding Universities for Research, Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8793-3076","authenticated-orcid":false,"given":"Jae Min","family":"Cho","sequence":"additional","affiliation":[{"name":"Brain Korea 21 Fostering Outstanding Universities for Research, Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4882-5621","authenticated-orcid":false,"given":"Hossam","family":"Nada","sequence":"additional","affiliation":[{"name":"Brain Korea 21 Fostering Outstanding Universities for Research, Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 02841, Republic of Korea"},{"name":"Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Seong","family":"Kim","sequence":"additional","affiliation":[{"name":"Brain Korea 21 Fostering Outstanding Universities for Research, Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peela","family":"Induvadana","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Jin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Radiology, College of Medicine Anam Hospital, Korea University, 73 Goryeodae-ro, Seongbuk-gu, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Brain Korea 21 Fostering Outstanding Universities for Research, Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongseok","family":"Choi","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ik","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, College of Medicine, Korea University, Seoul 73 Goryeodae-ro, Seongbuk-gu, Seoul 02841, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-Associated Molecular Patterns in Inflammatory Diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","article-title":"PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity","volume":"249","author":"Tang","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12964-025-02149-4","article-title":"An Examination of the lps-tlr4 Immune Response Through the Analysis of Molecular Structures and Protein\u2013Protein Interactions","volume":"23","author":"Luo","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2016.10.005","article-title":"Early Innate Immune Responses to Bacterial LPS","volume":"44","author":"Rosadini","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-Like Receptors and Innate Immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","article-title":"The Role of Inflammasomes in Human Diseases and their Potential as Therapeutic Targets","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: Mechanism of Action, Role in Disease, and Therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"ref_9","first-page":"5","article-title":"The Proteasome is Crucial for the Degradation of Viral and Bacterial Proteins","volume":"9","author":"Spinas","year":"2025","journal-title":"Int. J. Infect."},{"key":"ref_10","first-page":"100","article-title":"MAPK is Implicated in Sepsis, Immunity, and Inflammation","volume":"8","author":"Saggini","year":"2024","journal-title":"Int. J. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Petrilli, V., Papin, S., and Tschopp, J. (2005). The Inflammasome. Curr. Biol., 15.","DOI":"10.1016\/j.cub.2005.07.049"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of Inflammasome Activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhen, Y., and Zhang, H. (2019). NLRP3 Inflammasome and Inflammatory Bowel Disease. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00276"},{"key":"ref_15","first-page":"e4063562","article-title":"NLRP3 Inflammasome and Inflammatory Diseases","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chen, Y., Ye, X., Escames, G., Lei, W., Zhang, X., Li, M., Jing, T., Yao, Y., Qiu, Z., and Wang, Z. (2023). The NLRP3 Inflammasome: Contributions to Inflammation-Related Diseases. Cell. Mol. Biol. Lett., 28.","DOI":"10.1186\/s11658-023-00462-9"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 Inflammasome: Molecular Activation and Regulation to Therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Blevins, H.M., Xu, Y., Biby, S., and Zhang, S. (2022). The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.879021"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","article-title":"NOD-Like Receptors and Inflammasomes: A Review of their Canonical and Non-Canonical Signaling Pathways","volume":"670","author":"Platnich","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 Inflammasome: Activation and Regulation","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhan, X., Li, Q., Xu, G., Xiao, X., and Bai, Z. (2023). The Mechanism of NLRP3 Inflammasome Activation and its Pharmacological Inhibitors. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1109938"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nagar, A., Rahman, T., and Harton, J.A. (2021). The ASC Speck and NLRP3 Inflammasome Function are Spatially and Temporally Distinct. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.752482"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., and Di Paola, R. (2020). Focus on the Role of NLRP3 Inflammasome in Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124223"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","article-title":"Pharmacological inhibition of the NLRP3 inflammasome: Structure, molecular activation, and inhibitor-NLRP3 interaction","volume":"75","author":"Ma","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2147\/DMSO.S199802","article-title":"A Small Molecule Inhibitor Mcc950 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting Nlrp3 Inflammasome Activation","volume":"12","author":"Zhang","year":"2019","journal-title":"Diabetes, Metab. Syndr. Obesity: Targets Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"111822","DOI":"10.1016\/j.ejmech.2019.111822","article-title":"Development of Small Molecule Inhibitors Targeting Nlrp3 Inflammasome Pathway for Inflammatory Diseases","volume":"185","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A Small-Molecule Inhibitor of the Nlrp3 Inflammasome for the Treatment of Inflammatory Diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","article-title":"An Update on the Regulatory Mechanisms of Nlrp3 Inflammasome Activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/intimm\/dxx018","article-title":"Mechanisms Governing Inflammasome Activation, Assembly and Pyroptosis Induction","volume":"29","author":"Kesavardhana","year":"2017","journal-title":"Int. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40635-020-00350-y","article-title":"Comparison of Direct and Indirect Models of Early Induced Acute Lung Injury","volume":"8","author":"Chimenti","year":"2020","journal-title":"Intensiv. Care Med. Exp."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111847","DOI":"10.1016\/j.intimp.2024.111847","article-title":"SP-8356 Inhibits Acute Lung Injury by Suppressing Inflammatory Cytokine Production and Immune Cell Infiltration","volume":"131","author":"Nguyen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhou, X., Wang, Z., Wang, Y., Xu, G., Luo, M., Zhang, M., and Li, Y. (2025). Rutin Ameliorates Lps-Induced Acute Lung Injury in Mice by Inhibiting the Cgas-Sting-Nlrp3 Signaling Pathway. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1590096"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory Responses and Inflammation-Associated Diseases in Organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Van, T.P., Bao, T.H.T.N., Leya, M., Zhou, Z., Jeong, H., Lim, C.-W., and Kim, B. (2024). Amlexanox Attenuates Lps-Induced Neuroinflammatory Responses in Microglial Cells via Inhibition of Nf\u2013\u039ab and Stat3 Signaling Pathways. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-53235-5"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"Nf-\u039ab in Biology and Targeted Therapy: New Insights and Translational Implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT Signaling Pathway: From Bench to Clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 Directly Targets the Nlrp3 Atp-Hydrolysis Motif for Inflammasome Inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20241076","DOI":"10.1515\/med-2024-1076","article-title":"Progress in Cytokine Research for Ards: A Comprehensive Review","volume":"19","author":"Zhou","year":"2024","journal-title":"Open Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 Inflammasome Activation and Cell Death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5858\/arpa.2015-0519-RA","article-title":"Acute lung injury: A clinical and molecular review","volume":"140","author":"Butt","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ostwani, W., and Shanley, T.P. (2014). Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS). Pediatric Critical Care Medicine: Volume 2: Respiratory, Cardiovascular and Central Nervous Systems, Springer.","DOI":"10.1007\/978-1-4471-6356-5_7"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1631\/jzus.2007.B0060","article-title":"Acute Lung Injury\/Acute Respiratory Distress Syndrome (ALI\/ARDS): The Mechanism, Present Strategies and Future Perspectives of Therapies","volume":"8","author":"Luh","year":"2007","journal-title":"J. Zhejiang Univ. B"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.4049\/jimmunol.1400368","article-title":"Critical Role for the NLRP3 Inflammasome during Acute Lung Injury","volume":"192","author":"Grailer","year":"2014","journal-title":"J. Immunol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/10\/1241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:47:39Z","timestamp":1760035659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/10\/1241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["pharmaceutics17101241"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17101241","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}